[1]
Friede A, O'Carroll PW, Thralls RB, Reid JA. CDC WONDER on the Web. Proceedings : a conference of the American Medical Informatics Association. AMIA Fall Symposium. 1996:():408-12
[PubMed PMID: 8947698]
[2]
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018 Nov 10:392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8
[PubMed PMID: 30496103]
Level 1 (high-level) evidence
[3]
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. European heart journal. 2014 Nov 7:35(42):2929. doi: 10.1093/eurheartj/ehu378. Epub
[PubMed PMID: 25381246]
Level 2 (mid-level) evidence
[4]
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 Jan 29:117(4):e25-146
[PubMed PMID: 18086926]
[5]
Lloyd-Jones D,Adams RJ,Brown TM,Carnethon M,Dai S,De Simone G,Ferguson TB,Ford E,Furie K,Gillespie C,Go A,Greenlund K,Haase N,Hailpern S,Ho PM,Howard V,Kissela B,Kittner S,Lackland D,Lisabeth L,Marelli A,McDermott MM,Meigs J,Mozaffarian D,Mussolino M,Nichol G,Roger VL,Rosamond W,Sacco R,Sorlie P,Stafford R,Thom T,Wasserthiel-Smoller S,Wong ND,Wylie-Rosett J, Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23;
[PubMed PMID: 20177011]
[6]
Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. MMWR supplements. 2014 Oct 31:63(4):3-27
[PubMed PMID: 25356673]
[7]
Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart views : the official journal of the Gulf Heart Association. 2017 Jul-Sep:18(3):109-114. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17. Epub
[PubMed PMID: 29184622]
Level 3 (low-level) evidence
[8]
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (London, England). 2014 Mar 15:383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29
[PubMed PMID: 24084292]
Level 3 (low-level) evidence
[9]
Jousilahti P,Laatikainen T,Peltonen M,Borodulin K,Männistö S,Jula A,Salomaa V,Harald K,Puska P,Vartiainen E, Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study. BMJ (Clinical research ed.). 2016 Mar 1;
[PubMed PMID: 26932978]
Level 2 (mid-level) evidence
[10]
Lind L. Population-based cardiovascular cohort studies in Uppsala. Upsala journal of medical sciences. 2019 Jan:124(1):16-20. doi: 10.1080/03009734.2018.1515282. Epub 2018 Oct 3
[PubMed PMID: 30278808]
[11]
Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, D'Agostino RB Sr, Peterson ED, Sniderman AD. Quantifying Importance of Major Risk Factors for Coronary Heart Disease. Circulation. 2019 Mar 26:139(13):1603-1611. doi: 10.1161/CIRCULATIONAHA.117.031855. Epub
[PubMed PMID: 30586759]
[12]
Weir HK, Anderson RN, Coleman King SM, Soman A, Thompson TD, Hong Y, Moller B, Leadbetter S. Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020. Preventing chronic disease. 2016 Nov 17:13():E157. doi: 10.5888/pcd13.160211. Epub 2016 Nov 17
[PubMed PMID: 27854420]
[13]
Sanchis-Gomar F,Perez-Quilis C,Leischik R,Lucia A, Epidemiology of coronary heart disease and acute coronary syndrome. Annals of translational medicine. 2016 Jul;
[PubMed PMID: 27500157]
[14]
Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA Jr, Willis M, Yancy CW, American Heart Association Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 21:136(21):e393-e423. doi: 10.1161/CIR.0000000000000534. Epub 2017 Oct 23
[PubMed PMID: 29061565]
[15]
Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, Palaniappan L, Piña IL, Ramirez SM, Rodriguez B, Sims M, American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Cardiovascular and Stroke Nursing. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014 Aug 12:130(7):593-625. doi: 10.1161/CIR.0000000000000071. Epub 2014 Jul 14
[PubMed PMID: 25098323]
[16]
Volgman AS, Palaniappan LS, Aggarwal NT, Gupta M, Khandelwal A, Krishnan AV, Lichtman JH, Mehta LS, Patel HN, Shah KS, Shah SH, Watson KE, American Heart Association Council on Epidemiology and Prevention; Cardiovascular Disease and Stroke in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation. 2018 Jul 3:138(1):e1-e34. doi: 10.1161/CIR.0000000000000580. Epub 2018 May 24
[PubMed PMID: 29794080]
[17]
Bachmann JM,Willis BL,Ayers CR,Khera A,Berry JD, Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation. 2012 Jun 26;
[PubMed PMID: 22623718]
[18]
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27:131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17
[PubMed PMID: 25520374]
[19]
Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM. Lifetime risks of cardiovascular disease. The New England journal of medicine. 2012 Jan 26:366(4):321-9. doi: 10.1056/NEJMoa1012848. Epub
[PubMed PMID: 22276822]
[20]
Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS medicine. 2009 Apr 28:6(4):e1000058. doi: 10.1371/journal.pmed.1000058. Epub 2009 Apr 28
[PubMed PMID: 19399161]
Level 2 (mid-level) evidence
[21]
Merai R,Siegel C,Rakotz M,Basch P,Wright J,Wong B,Thorpe P, CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension. MMWR. Morbidity and mortality weekly report. 2016 Nov 18;
[PubMed PMID: 27855138]
[22]
Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology. 2019 Aug:234(10):16812-16823. doi: 10.1002/jcp.28350. Epub 2019 Feb 20
[PubMed PMID: 30790284]
[23]
Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension (Dallas, Tex. : 1979). 1995 Feb:25(2):155-61
[PubMed PMID: 7843763]
Level 3 (low-level) evidence
[24]
Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996 May 22-29:275(20):1571-6
[PubMed PMID: 8622248]
[25]
Abd Alamir M,Goyfman M,Chaus A,Dabbous F,Tamura L,Sandfort V,Brown A,Budoff M, The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis. Journal of lipids. 2018
[PubMed PMID: 29785308]
[26]
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5:139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. Epub
[PubMed PMID: 30700139]
[27]
Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C, Rodriguez-Artalejo F, Martínez-Vizcaíno V. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ open. 2017 Jul 31:7(7):e015949. doi: 10.1136/bmjopen-2017-015949. Epub 2017 Jul 31
[PubMed PMID: 28760792]
Level 1 (high-level) evidence
[28]
American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019. Diabetes care. 2019 Jan:42(Suppl 1):S103-S123. doi: 10.2337/dc19-S010. Epub
[PubMed PMID: 30559236]
[29]
Wilson PW,D'Agostino RB,Sullivan L,Parise H,Kannel WB, Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of internal medicine. 2002 Sep 9;
[PubMed PMID: 12196085]
[30]
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25:112(17):2735-52
[PubMed PMID: 16157765]
[31]
Ades PA, Savage PD. Obesity in coronary heart disease: An unaddressed behavioral risk factor. Preventive medicine. 2017 Nov:104():117-119. doi: 10.1016/j.ypmed.2017.04.013. Epub 2017 Apr 13
[PubMed PMID: 28414064]
[32]
Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G, Nambi V, Ballantyne CM, Solomon SD, Selvin E, Folsom AR, Coresh J. Obesity and Subtypes of Incident Cardiovascular Disease. Journal of the American Heart Association. 2016 Jul 28:5(8):. doi: 10.1161/JAHA.116.003921. Epub 2016 Jul 28
[PubMed PMID: 27468925]
[33]
Garcia-Labbé D,Ruka E,Bertrand OF,Voisine P,Costerousse O,Poirier P, Obesity and coronary artery disease: evaluation and treatment. The Canadian journal of cardiology. 2015 Feb
[PubMed PMID: 25661553]
[34]
McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. The American journal of cardiology. 1998 Nov 26:82(10B):30T-36T
[PubMed PMID: 9860371]
[35]
Akin I, Nienaber CA. "Obesity paradox" in coronary artery disease. World journal of cardiology. 2015 Oct 26:7(10):603-8. doi: 10.4330/wjc.v7.i10.603. Epub
[PubMed PMID: 26516414]
[36]
Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation. 2015 Nov 10:132(19):1795-804. doi: 10.1161/CIRCULATIONAHA.115.017926. Epub 2015 Aug 26
[PubMed PMID: 26311724]
Level 1 (high-level) evidence
[37]
Mons U,Müezzinler A,Gellert C,Schöttker B,Abnet CC,Bobak M,de Groot L,Freedman ND,Jansen E,Kee F,Kromhout D,Kuulasmaa K,Laatikainen T,O'Doherty MG,Bueno-de-Mesquita B,Orfanos P,Peters A,van der Schouw YT,Wilsgaard T,Wolk A,Trichopoulou A,Boffetta P,Brenner H, Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ (Clinical research ed.). 2015 Apr 20
[PubMed PMID: 25896935]
Level 1 (high-level) evidence
[38]
Japuntich SJ, Eilers MA, Shenhav S, Park ER, Winickoff JP, Benowitz NL, Rigotti NA. Secondhand tobacco smoke exposure among hospitalized nonsmokers with coronary heart disease. JAMA internal medicine. 2015 Jan:175(1):133-6. doi: 10.1001/jamainternmed.2014.5476. Epub
[PubMed PMID: 25383761]
[39]
Temple NJ. Fat, Sugar, Whole Grains and Heart Disease: 50 Years of Confusion. Nutrients. 2018 Jan 4:10(1):. doi: 10.3390/nu10010039. Epub 2018 Jan 4
[PubMed PMID: 29300309]
[40]
Anand SS, Hawkes C, de Souza RJ, Mente A, Dehghan M, Nugent R, Zulyniak MA, Weis T, Bernstein AM, Krauss RM, Kromhout D, Jenkins DJA, Malik V, Martinez-Gonzalez MA, Mozaffarian D, Yusuf S, Willett WC, Popkin BM. Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. Journal of the American College of Cardiology. 2015 Oct 6:66(14):1590-1614. doi: 10.1016/j.jacc.2015.07.050. Epub
[PubMed PMID: 26429085]
[41]
Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10
[PubMed PMID: 31498691]
Level 1 (high-level) evidence
[42]
Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. The New England journal of medicine. 2006 Apr 13:354(15):1601-13
[PubMed PMID: 16611951]
[43]
Narain A, Kwok CS, Mamas MA. Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. International journal of clinical practice. 2016 Oct:70(10):791-805. doi: 10.1111/ijcp.12841. Epub 2016 Jul 25
[PubMed PMID: 27456347]
Level 1 (high-level) evidence
[44]
Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA internal medicine. 2014 Apr:174(4):516-24. doi: 10.1001/jamainternmed.2013.13563. Epub
[PubMed PMID: 24493081]
[45]
DiNicolantonio JJ, OKeefe JH. Added sugars drive coronary heart disease via insulin resistance and hyperinsulinaemia: a new paradigm. Open heart. 2017:4(2):e000729. doi: 10.1136/openhrt-2017-000729. Epub 2017 Nov 29
[PubMed PMID: 29225905]
[46]
Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010 Jun 1:121(21):2271-83. doi: 10.1161/CIRCULATIONAHA.109.924977. Epub 2010 May 17
[PubMed PMID: 20479151]
Level 1 (high-level) evidence
[47]
Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, Nailler L, Boutron-Ruault MC, Clavel-Chapelon F, Krogh V, Palli D, Panico S, Tumino R, Ricceri F, Bergmann MM, Boeing H, Li K, Kaaks R, Khaw KT, Wareham NJ, Crowe FL, Key TJ, Naska A, Trichopoulou A, Trichopoulos D, Leenders M, Peeters PH, Engeset D, Parr CL, Skeie G, Jakszyn P, Sánchez MJ, Huerta JM, Redondo ML, Barricarte A, Amiano P, Drake I, Sonestedt E, Hallmans G, Johansson I, Fedirko V, Romieux I, Ferrari P, Norat T, Vergnaud AC, Riboli E, Linseisen J. Meat consumption and mortality--results from the European Prospective Investigation into Cancer and Nutrition. BMC medicine. 2013 Mar 7:11():63. doi: 10.1186/1741-7015-11-63. Epub 2013 Mar 7
[PubMed PMID: 23497300]
[48]
Larsson SC, Orsini N. Red meat and processed meat consumption and all-cause mortality: a meta-analysis. American journal of epidemiology. 2014 Feb 1:179(3):282-9. doi: 10.1093/aje/kwt261. Epub 2013 Oct 22
[PubMed PMID: 24148709]
Level 1 (high-level) evidence
[49]
Wolk A. Potential health hazards of eating red meat. Journal of internal medicine. 2017 Feb:281(2):106-122. doi: 10.1111/joim.12543. Epub 2016 Sep 6
[PubMed PMID: 27597529]
[50]
Bechthold A, Boeing H, Schwedhelm C, Hoffmann G, Knüppel S, Iqbal K, De Henauw S, Michels N, Devleesschauwer B, Schlesinger S, Schwingshackl L. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Critical reviews in food science and nutrition. 2019:59(7):1071-1090. doi: 10.1080/10408398.2017.1392288. Epub 2017 Nov 7
[PubMed PMID: 29039970]
Level 1 (high-level) evidence
[51]
Alshahrani SM, Fraser GE, Sabaté J, Knutsen R, Shavlik D, Mashchak A, Lloren JI, Orlich MJ. Red and Processed Meat and Mortality in a Low Meat Intake Population. Nutrients. 2019 Mar 14:11(3):. doi: 10.3390/nu11030622. Epub 2019 Mar 14
[PubMed PMID: 30875776]
[52]
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England). 2004 Sep 11-17:364(9438):937-52
[PubMed PMID: 15364185]
Level 2 (mid-level) evidence
[53]
Tana C, Ballestri S, Ricci F, Di Vincenzo A, Ticinesi A, Gallina S, Giamberardino MA, Cipollone F, Sutton R, Vettor R, Fedorowski A, Meschi T. Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. International journal of environmental research and public health. 2019 Aug 26:16(17):. doi: 10.3390/ijerph16173104. Epub 2019 Aug 26
[PubMed PMID: 31455011]
[54]
Mahfood Haddad T, Hamdeh S, Kanmanthareddy A, Alla VM. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. Diabetes & metabolic syndrome. 2017 Nov:11 Suppl 1():S209-S216. doi: 10.1016/j.dsx.2016.12.033. Epub 2016 Dec 15
[PubMed PMID: 28017631]
[55]
Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020 Sep:18(10):2324-2331.e4. doi: 10.1016/j.cgh.2019.12.026. Epub 2019 Dec 27
[PubMed PMID: 31887443]
[56]
Cai Q, Mukku VK, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Current cardiology reviews. 2013 Nov:9(4):331-9
[PubMed PMID: 24527682]
[57]
. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10:140(11):e647-e648. doi: 10.1161/CIR.0000000000000724. Epub 2019 Sep 9
[PubMed PMID: 31498692]
Level 1 (high-level) evidence
[58]
Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Current cardiology reviews. 2008 May:4(2):116-22. doi: 10.2174/157340308784245775. Epub
[PubMed PMID: 19936286]
[59]
Fors Nieves CE, Izmirly PM. Mortality in Systemic Lupus Erythematosus: an Updated Review. Current rheumatology reports. 2016 Apr:18(4):21. doi: 10.1007/s11926-016-0571-2. Epub
[PubMed PMID: 26984805]
[60]
Dein E, Douglas H, Petri M, Law G, Timlin H. Pericarditis in Lupus. Cureus. 2019 Mar 1:11(3):e4166. doi: 10.7759/cureus.4166. Epub 2019 Mar 1
[PubMed PMID: 31086751]
[61]
Bezwada P, Quadri A, Shaikh A, Ayala-Rodriguez C, Green S. Myopericarditis and Pericardial Effusion as the Initial Presentation of Systemic Lupus Erythematosus. Case reports in medicine. 2017:2017():6912020. doi: 10.1155/2017/6912020. Epub 2017 Feb 5
[PubMed PMID: 28261271]
Level 3 (low-level) evidence
[62]
Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. American heart journal. 2013 Oct:166(4):622-628.e1. doi: 10.1016/j.ahj.2013.07.010. Epub 2013 Aug 29
[PubMed PMID: 24093840]
[63]
Feng W, Chen G, Cai D, Zhao S, Cheng J, Shen H. Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies. Journal of the American Heart Association. 2017 Aug 2:6(8):. doi: 10.1161/JAHA.117.005892. Epub 2017 Aug 2
[PubMed PMID: 28768646]
[64]
Sinha A, Feinstein MJ. Coronary Artery Disease Manifestations in HIV: What, How, and Why. The Canadian journal of cardiology. 2019 Mar:35(3):270-279. doi: 10.1016/j.cjca.2018.11.029. Epub 2018 Dec 4
[PubMed PMID: 30825949]
[65]
Cappola AR, Desai AS, Medici M, Cooper LS, Egan D, Sopko G, Fishman GI, Goldman S, Cooper DS, Mora S, Kudenchuk PJ, Hollenberg AN, McDonald CL, Ladenson PW. Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment. Circulation. 2019 Jun 18:139(25):2892-2909. doi: 10.1161/CIRCULATIONAHA.118.036859. Epub 2019 May 13
[PubMed PMID: 31081673]
[66]
Central action of nomifensine., Maj J,Kapturkiewicz Z,Michaluk J,, Polish journal of pharmacology and pharmacy, 1976 Nov-Dec
[PubMed PMID: 23246686]
[67]
LeFevre ML, U.S. Preventive Services Task Force. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2015 May 5:162(9):641-50. doi: 10.7326/M15-0483. Epub
[PubMed PMID: 25798805]
[68]
Bianchi VE. Testosterone, myocardial function, and mortality. Heart failure reviews. 2018 Sep:23(5):773-788. doi: 10.1007/s10741-018-9721-0. Epub
[PubMed PMID: 29978359]
[69]
[Energy transfer in photosynthetic units (author's transl)]., Frackowiak D,Fiksiński K,, Postepy biochemii, 1976
[PubMed PMID: 29275030]
[70]
Goodale T, Sadhu A, Petak S, Robbins R. Testosterone and the Heart. Methodist DeBakey cardiovascular journal. 2017 Apr-Jun:13(2):68-72. doi: 10.14797/mdcj-13-2-68. Epub
[PubMed PMID: 28740585]
[72]
Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clinic proceedings. 2015 Feb:90(2):224-51
[PubMed PMID: 25636998]
Level 3 (low-level) evidence
[73]
Modarresi-Ghazani F, Hejazi ME, Gharekhani A, Entezari-Maleki T. Role of Vitamin D in Cardiovascular Disease. Archives of Iranian medicine. 2016 May:19(5):359-62
[PubMed PMID: 27179169]
[74]
Aggarwal R, Akhthar T, Jain SK. Coronary artery disease and its association with Vitamin D deficiency. Journal of mid-life health. 2016 Apr-Jun:7(2):56-60. doi: 10.4103/0976-7800.185334. Epub
[PubMed PMID: 27499590]
[75]
Siadat ZD, Kiani K, Sadeghi M, Shariat AS, Farajzadegan Z, Kheirmand M. Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2012 Nov:17(11):1052-5
[PubMed PMID: 23833580]
Level 3 (low-level) evidence
[76]
Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clinical hypertension. 2018:24():9. doi: 10.1186/s40885-018-0094-4. Epub 2018 Jun 22
[PubMed PMID: 29977597]
[77]
Rai V, Agrawal DK. Role of Vitamin D in Cardiovascular Diseases. Endocrinology and metabolism clinics of North America. 2017 Dec:46(4):1039-1059. doi: 10.1016/j.ecl.2017.07.009. Epub 2017 Sep 29
[PubMed PMID: 29080634]
[78]
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29:117(4):503-11. doi: 10.1161/CIRCULATIONAHA.107.706127. Epub 2008 Jan 7
[PubMed PMID: 18180395]
[79]
Kunadian V, Ford GA, Bawamia B, Qiu W, Manson JE. Vitamin D deficiency and coronary artery disease: a review of the evidence. American heart journal. 2014 Mar:167(3):283-91. doi: 10.1016/j.ahj.2013.11.012. Epub 2013 Dec 19
[PubMed PMID: 24576510]
[80]
Nuclear coupling of 33S and the nature of free radicals in irradiated crystals of N-acetyl-L-cysteine., Hadley JH Jr,Gordy W,, Proceedings of the National Academy of Sciences of the United States of America, 1977 Jan
[PubMed PMID: 27081110]
[81]
Gulati M, Shaw LJ, Bairey Merz CN. Myocardial ischemia in women: lessons from the NHLBI WISE study. Clinical cardiology. 2012 Mar:35(3):141-8. doi: 10.1002/clc.21966. Epub
[PubMed PMID: 22389117]
Level 3 (low-level) evidence
[82]
Burke AP, Farb A, Malcom G, Virmani R. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. American heart journal. 2001 Feb:141(2 Suppl):S58-62
[PubMed PMID: 11174360]
[83]
Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. Journal of the American College of Cardiology. 2009 Oct 20:54(17):1561-75. doi: 10.1016/j.jacc.2009.04.098. Epub
[PubMed PMID: 19833255]
[84]
Siu AL, Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2015 Nov 17;
[PubMed PMID: 26458123]
[85]
Moyer VA, U.S. Preventive Services Task Force. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics. 2013 Nov:132(5):907-14. doi: 10.1542/peds.2013-2864. Epub 2013 Oct 7
[PubMed PMID: 24101758]
[86]
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. Journal of hypertension. 2016 Apr:34(4):613-22. doi: 10.1097/HJH.0000000000000881. Epub
[PubMed PMID: 26848994]
Level 3 (low-level) evidence
[87]
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (London, England). 2002 Dec 14:360(9349):1903-13
[PubMed PMID: 12493255]
Level 2 (mid-level) evidence
[88]
Kannel WB. Hypertension: reflections on risks and prognostication. The Medical clinics of North America. 2009 May:93(3):541-58, Table of Contents. doi: 10.1016/j.mcna.2009.02.006. Epub
[PubMed PMID: 19427490]
[89]
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FAR, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016 Nov 15:316(19):1997-2007. doi: 10.1001/jama.2016.15450. Epub
[PubMed PMID: 27838723]
[90]
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre M, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP, Siu AL. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2016 Aug 9:316(6):625-33. doi: 10.1001/jama.2016.9852. Epub
[PubMed PMID: 27532917]
[91]
de Ferranti SD, Rodday AM, Parsons SK, Cull WL, O'Connor KG, Daniels SR, Leslie LK. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians. The Journal of pediatrics. 2017 Jun:185():99-105.e2. doi: 10.1016/j.jpeds.2016.12.078. Epub 2017 Feb 13
[PubMed PMID: 28209292]
[92]
Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (Clinical research ed.). 1994 Feb 5:308(6925):367-72
[PubMed PMID: 8043072]
[93]
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England journal of medicine. 2008 Nov 20:359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9
[PubMed PMID: 18997196]
[94]
Siu AL, Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2015 Dec 1;
[PubMed PMID: 26501513]
[95]
Giugliano D, Chiodini P, Maiorino MI, Bellastella G, Esposito K. Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysis. Journal of endocrinological investigation. 2019 Oct:42(10):1165-1169. doi: 10.1007/s40618-019-01047-0. Epub 2019 Apr 6
[PubMed PMID: 30955180]
[96]
Pallazola VA,Davis DM,Whelton SP,Cardoso R,Latina JM,Michos ED,Sarkar S,Blumenthal RS,Arnett DK,Stone NJ,Welty FK, A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention. Mayo Clinic proceedings. Innovations, quality & outcomes. 2019 Sep
[PubMed PMID: 31485563]
Level 2 (mid-level) evidence
[97]
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. The New England journal of medicine. 2001 Jan 4:344(1):3-10
[PubMed PMID: 11136953]
[98]
Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases--incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition (Burbank, Los Angeles County, Calif.). 2013 Apr:29(4):611-8. doi: 10.1016/j.nut.2012.12.018. Epub
[PubMed PMID: 23466047]
[99]
Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. International journal of epidemiology. 2017 Jun 1:46(3):1029-1056. doi: 10.1093/ije/dyw319. Epub
[PubMed PMID: 28338764]
Level 1 (high-level) evidence
[100]
Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC medicine. 2016 Dec 5:14(1):207
[PubMed PMID: 27916000]
[101]
Mattioli AV, Palmiero P, Manfrini O, Puddu PE, Nodari S, Dei Cas A, Mercuro G, Scrutinio D, Palermo P, Sciomer S, Di Francesco S, Novo G, Novo S, Pedretti RFE, Zito A, Parati G, Pedrinelli R, Farinetti A, Maiello M, Moscucci F, Tenaglia RL, Sucato V, Triggiani M, Cugusi L, Scicchitano P, Saba PS, Ciccone MM. Mediterranean diet impact on cardiovascular diseases: a narrative review. Journal of cardiovascular medicine (Hagerstown, Md.). 2017 Dec:18(12):925-935. doi: 10.2459/JCM.0000000000000573. Epub
[PubMed PMID: 28914660]
Level 3 (low-level) evidence
[102]
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019 Sep 10:74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17
[PubMed PMID: 30894318]
Level 1 (high-level) evidence
[103]
Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS medicine. 2010 Mar 23:7(3):e1000252. doi: 10.1371/journal.pmed.1000252. Epub 2010 Mar 23
[PubMed PMID: 20351774]
Level 1 (high-level) evidence
[104]
Siu AL, U.S. Preventive Services Task Force. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2015 Oct 20:163(8):622-34. doi: 10.7326/M15-2023. Epub 2015 Sep 22
[PubMed PMID: 26389730]
[105]
Moyer VA, U.S. Preventive Services Task Force. Primary care interventions to prevent tobacco use in children and adolescents: U.S. preventive services task force recommendation statement. Pediatrics. 2013 Sep:132(3):560-5. doi: 10.1542/peds.2013-2079. Epub 2013 Aug 26
[PubMed PMID: 23979083]
[106]
Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM. 50-year trends in smoking-related mortality in the United States. The New England journal of medicine. 2013 Jan 24:368(4):351-64. doi: 10.1056/NEJMsa1211127. Epub
[PubMed PMID: 23343064]
[108]
Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. The Cochrane database of systematic reviews. 2012 Nov 14:11():CD000146. doi: 10.1002/14651858.CD000146.pub4. Epub 2012 Nov 14
[PubMed PMID: 23152200]
Level 1 (high-level) evidence
[109]
Cahill K,Lindson-Hawley N,Thomas KH,Fanshawe TR,Lancaster T, Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews. 2016 May 9
[PubMed PMID: 27158893]
Level 1 (high-level) evidence
[110]
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. The Cochrane database of systematic reviews. 2014 Jan 8:2014(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Epub 2014 Jan 8
[PubMed PMID: 24402784]
Level 1 (high-level) evidence
[111]
Stead LF,Koilpillai P,Fanshawe TR,Lancaster T, Combined pharmacotherapy and behavioural interventions for smoking cessation. The Cochrane database of systematic reviews. 2016 Mar 24;
[PubMed PMID: 27009521]
Level 1 (high-level) evidence
[112]
US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Grossman DC, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB. Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Sep 18:320(11):1163-1171. doi: 10.1001/jama.2018.13022. Epub
[PubMed PMID: 30326502]
[113]
Cleo G, Beller E, Glasziou P, Isenring E, Thomas R. Efficacy of habit-based weight loss interventions: a systematic review and meta-analysis. Journal of behavioral medicine. 2020 Aug:43(4):519-532. doi: 10.1007/s10865-019-00100-w. Epub 2019 Sep 16
[PubMed PMID: 31529279]
Level 1 (high-level) evidence
[114]
LeFevre ML, U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2014 Oct 21:161(8):587-93. doi: 10.7326/M14-1796. Epub
[PubMed PMID: 25155419]
[115]
Shaw K,Gennat H,O'Rourke P,Del Mar C, Exercise for overweight or obesity. The Cochrane database of systematic reviews. 2006 Oct 18;
[PubMed PMID: 17054187]
Level 1 (high-level) evidence
[116]
Schoenborn CA, Stommel M. Adherence to the 2008 adult physical activity guidelines and mortality risk. American journal of preventive medicine. 2011 May:40(5):514-21. doi: 10.1016/j.amepre.2010.12.029. Epub
[PubMed PMID: 21496750]
[117]
Sattelmair J, Pertman J, Ding EL, Kohl HW 3rd, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011 Aug 16:124(7):789-95. doi: 10.1161/CIRCULATIONAHA.110.010710. Epub 2011 Aug 1
[PubMed PMID: 21810663]
Level 1 (high-level) evidence
[118]
Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. The Cochrane database of systematic reviews. 2009 Jul 8:2009(3):CD002759. doi: 10.1002/14651858.CD002759.pub2. Epub 2009 Jul 8
[PubMed PMID: 19588334]
Level 1 (high-level) evidence
[119]
Crowding stress and adrenal mitochondrial 11 beta-hydroxylation in vitro., Mccarthy JL,Green W,Sohal RS,, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1976 Dec
[PubMed PMID: 31226053]
[120]
Lin KW, Middleton J. Rethinking Aspirin for the Primary Prevention of Cardiovascular Disease. American family physician. 2019 Jun 1:99(11):670-671
[PubMed PMID: 31150176]
[121]
Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. JACC. Cardiovascular imaging. 2017 Feb:10(2):143-153. doi: 10.1016/j.jcmg.2016.03.022. Epub 2016 Sep 21
[PubMed PMID: 27665163]
[122]
Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk. Journal of the American College of Cardiology. 2018 Jul 24:72(4):434-447. doi: 10.1016/j.jacc.2018.05.027. Epub
[PubMed PMID: 30025580]
[123]
Naqvi TZ,Lee MS, Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC. Cardiovascular imaging. 2014 Oct
[PubMed PMID: 25051948]
[124]
Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O'Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Witteman JC, Moons KG, Bots ML. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012 Aug 22:308(8):796-803. doi: 10.1001/jama.2012.9630. Epub
[PubMed PMID: 22910757]
[125]
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2010 Dec 14:56(25):e50-103. doi: 10.1016/j.jacc.2010.09.001. Epub
[PubMed PMID: 21144964]
[126]
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014 Jul 1:63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005. Epub 2013 Nov 12
[PubMed PMID: 24239921]
Level 3 (low-level) evidence
[127]
Neuropeptide MSH/ACTH 4-10 enhances attention in the mentally retarded., Sandman CA,George J,Walker BB,Nolan JD,Kastin AJ,, Pharmacology, biochemistry, and behavior, 1976
[PubMed PMID: 28110311]
[128]
Widmer RJ, Samuels B, Samady H, Price MJ, Jeremias A, Anderson RD, Jaffer FA, Escaned J, Davies J, Prasad M, Grines C, Lerman A. The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2019 Mar 20:14(16):1694-1702. doi: 10.4244/EIJ-D-18-00982. Epub
[PubMed PMID: 30561368]
[129]
Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A. Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 2015 Nov 13:4(11):. doi: 10.1161/JAHA.115.002270. Epub 2015 Nov 13
[PubMed PMID: 26567372]
Level 1 (high-level) evidence
[130]
Rusnak J, Fastner C, Behnes M, Mashayekhi K, Borggrefe M, Akin I. Biomarkers in Stable Coronary Artery Disease. Current pharmaceutical biotechnology. 2017:18(6):456-471. doi: 10.2174/1389201018666170630120805. Epub
[PubMed PMID: 28669333]